Immunoprecise Antibodies shares owned by Citigroup
Quarter-by-quarter ownership of Immunoprecise Antibodies (IPA) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Immunoprecise Antibodies
Tip: Access up to 7 years of quarterly data
All positions including Immunoprecise Antibodies held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunoprecise Antibodies by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $12 | 7 | 1.71 |
| 2023-09-30 | $12 | 7 | 1.86 |
| 2023-03-31 | $19 | 7 | 2.71 |
| 2022-12-31 | $36 | 7 | 5.14 |
| 2022-09-30 | $0 | 7 | 0.00 |
| 2021-12-31 | $0 | 7 | 0.00 |
| 2021-03-31 | $0 | 7 | 0.00 |
| 2020-12-31 | $0 | 7 | 0.00 |